Posts

Showing posts from February, 2025

Builder Delayed Your Property? Here’s How to Get a Refund with Interest

  Case: Refund Claim under RERA – Ozone Urbana Project 1 min read Introduction  This case, filed under Sections 12 and 18 of the Real Estate (Regulation and Development) Act, 2016 (RERA), involves a complaint against the project Ozone Urbana for refunding the paid amount of ₹38,00,998/- with interest. The complainant cited the respondent's failure to adhere to the agreement terms, including delay in project completion and changing the possession date without consent. Key Facts of the case: Agreement Details: Initial sale agreement dated 10.07.2018. Revised agreement on 25.10.2021 included the complainant's husband as a co-buyer. Project Completion Dates: Original completion date: December 2022. Revised completion date (without consent): September 2023. Payments: The complainants paid ₹38,00,998/-. Complaint Filing: The complainants filed a case for refund with interest citing non-complet...

Claim Restrictions of Insurance Rejected: Cancer Patient Secures Justice.

  Garima Singh v. New India Assurance Co. Ltd. in the Delhi High Court revolves around cancer treatment and insurance claims. 1 min read: - Facts: Diagnosis & Treatment: The petitioner, Garima Singh , was diagnosed with Stage-IV breast cancer in 2021. The cancer spread to the lymph nodes and lungs . She underwent Chemo-immunotherapy , a combination of chemotherapy and immunotherapy. Insurance Claim Dispute: She held a health insurance policy covering Rs. 44.5 lakhs . The insurance company refused to fully reimburse her treatment costs, citing a sub-limit of Rs. 2 lakhs for Monoclonal Antibody injections . The Insurance Ombudsman ruled in her favor , directing the insurer to pay for the treatment . But the insurance company failed to comply with the order. Legal Arguments: The cancer Patient had approached Hon’ble High Court for directing the Insurance company to comply with the order.  The petitioner argued that Chemo-immunotherapy is different from Monoclonal Antibody i...